Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
February 9, 2022 SC 13G/A

An amendment to the SC 13G filing

View HTML
February 7, 2022 SC 13G/A

An amendment to the SC 13G filing

View HTML
January 28, 2022 S-8

Securities offered to employees pursuant to employee benefit plans

View HTML
January 24, 2022 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
January 5, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
December 30, 2021 CT ORDER

CT ORDER

View HTML
December 15, 2021 8-K/A

Amendment to a previously filed 8-K

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 4, 2021 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 4, 2021 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 3, 2021 3

Initial filing by director officer or owner of more than ten percent.

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us